高级检索
    范静静, 应长江, 姚楚晨, 李伟. 左甲状腺素及小剂量甲硫咪唑联合治疗Graves甲亢的临床疗效观察[J]. 徐州医科大学学报, 2018, 38(11): 719-722.
    引用本文: 范静静, 应长江, 姚楚晨, 李伟. 左甲状腺素及小剂量甲硫咪唑联合治疗Graves甲亢的临床疗效观察[J]. 徐州医科大学学报, 2018, 38(11): 719-722.
    FAN Jingjing, YING Changjing, YAO Chuchen, LI Wei. Effect of levothyroxine and low dose methinmazole on the treatment of Graves’ hyperthyroidism[J]. Journal of Xuzhou Medical University, 2018, 38(11): 719-722.
    Citation: FAN Jingjing, YING Changjing, YAO Chuchen, LI Wei. Effect of levothyroxine and low dose methinmazole on the treatment of Graves’ hyperthyroidism[J]. Journal of Xuzhou Medical University, 2018, 38(11): 719-722.

    左甲状腺素及小剂量甲硫咪唑联合治疗Graves甲亢的临床疗效观察

    Effect of levothyroxine and low dose methinmazole on the treatment of Graves’ hyperthyroidism

    • 摘要: 目的 对左甲状腺素和小剂量甲硫咪唑联合用药治疗Graves甲亢的临床疗效进行探讨。方法 将入组的162例Graves甲亢患者随机分为对照组(小剂量甲硫咪唑治疗,79例)、观察组(甲状腺素+小剂量甲硫咪唑治疗,83例)。对照组在前3个月口服小剂量甲硫咪唑片,剂量控制在10~20mg/d,1次/d,后续根据病情情况逐步减少剂量至维持剂量(2.5~7.5mg/d)。观察组在对照组的治疗基础上服用左甲状腺素片(25μg/d,2次/d)。治疗前后比较2组患者的甲状腺功能指标,对治疗中的不良反应和治疗结束后的复发情况进行比较。结果 在治疗12个月时,与对照组同期相比较,观察组的甲状 腺功能指标游离三碘甲状腺原氨酸(FT3)、促甲状腺素(TSH)、血清游离甲状腺素(FT4)和促甲状腺激素受体抗体(TRAb)均有明显改善(P﹤0.05),有效率有明显提高(P﹤0.05),不良反应发生率未发现有显著性差异(P﹥0.05);治疗后观察组在复发率与对照组相比,有明显降低(P﹤0.05)。结论 在Graves甲亢的药物治疗中,采用左甲状腺素和小剂量甲硫咪唑联合治疗方案,具有临床疗效好、安全性高和复发率低的优点。

       

      Abstract: Objective To investigate clinical efficacy of levothyroxine combined with low dose methionazole on the treatment of Graves’ hyperthyroidism. Methods 162 cases of Graves’ hyperthyroidism were randomly divided into the control group (low dose of methimidazole treatment, 79 cases) and the observation group (thyroxine + low dose of methimidazole treatment, 83 cases). The control group was given small dose methimazole, the initial dose 10~20mg/d, 1 times/d, 3 months later, gradually reduced the dose to 2.5~7.5mg/d maintenance according to condition of the patients. On basis of the control group’s treatment, the observation group was given levothyroxine (25μg/d and 2 times/d). Observe and compare the 2 groups of patients’ thyroid function indicators before and after treatment, adverse reactions in the treatment process and the recurrence after treatment. Results At 12 months of treatment, compared with the control group, the thyroid function indexes of the observation group were significantly improved (P < 0.05), the effective rate was significantly higher (P < 0.05), and the incidence of adverse reactions were no significant difference (P > 0.05). After the treatment, the recurrence rate was significantly lower in the observation group than in the control group ( P < 0.05). Conclusion Levothyroxine combined with low dose methionazole on the treatment of Graves’ hyperthyroidism has good clinical efficacy, high safety and low recurrence rate

       

    /

    返回文章
    返回